Stephen F. Betz, Chief Scientific Officer: Crinetics Pharmaceuticals CRNX Sell · Filed 23/01/19

Trade details

Type: Insider sale
Amount: $56,268
Shares · price: 3,126 sh · $18.00 a share
Held after: 76,151 sh
Stock: Crinetics Pharmaceuticals CRNX
Person: Stephen F. BetzChief Scientific Officer
Trade date: 23/01/17
Filed: 23/01/19
Days to filing: 2 days

Sold 3.9% of holdings

Share of holding sold: 3.9%

Crinetics Pharmaceuticals trades, last 26 weeks

What else happened in Crinetics Pharmaceuticals around then

Filed or reported within 30 days of the trade day · 22/12/18~23/02/16

Stephen F. Betz's recent trades

Stephen F. BetzChief Scientific Officer
Sell10b5-1 planCrinetics Pharmaceuticals
Sell10b5-1 plan
Crinetics Pharmaceuticals
CRNX
$236.4K
6,371 sh
$236.4K
Filed 03/18
Traded 03/16
Stephen F. BetzChief Scientific Officer
Sell10b5-1 planCrinetics Pharmaceuticals
Sell10b5-1 plan
Crinetics Pharmaceuticals
CRNX
$160.2K
4,241 sh
$160.2K
Filed 03/18
Traded 03/16
Stephen F. BetzChief Scientific Officer
Sell10b5-1 planCrinetics Pharmaceuticals
Sell10b5-1 plan
Crinetics Pharmaceuticals
CRNX
$3.1M
97,483 sh
$3.1M
Filed 25/06/16
Traded 25/06/12
Stephen F. BetzChief Scientific Officer
Sell10b5-1 planCrinetics Pharmaceuticals
Sell10b5-1 plan
Crinetics Pharmaceuticals
CRNX
$187.2K
5,479 sh
$187.2K
Filed 25/03/21
Traded 25/03/19
Stephen F. BetzChief Scientific Officer
Sell10b5-1 planCrinetics Pharmaceuticals
Sell10b5-1 plan
Crinetics Pharmaceuticals
CRNX
$10.1K
291 sh
$10.1K
Filed 25/03/21
Traded 25/03/19